<http://schema.org/description>
"Amarin jumps on news that the FDA will delay a decision on Vascepa until a decision on an appeal is heard. Unfortunately, Merck&amp;#39;s and AbbVie&amp;#39;s trial data still put a dark cloud over the decision."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2013/12/20/no-news-is-good-news-for-amarin.aspx>